APA (7th ed.) Citation

Balzano, N., Mascolo, A., Ruggiero, D., Rafaniello, C., Paolisso, G., Rossi, F., & Capuano, A. Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: Insights from FDA Adverse Event Reporting System. SAGE Publishing.

Chicago Style (17th ed.) Citation

Balzano, Nunzia, Annamaria Mascolo, Donatella Ruggiero, Concetta Rafaniello, Giuseppe Paolisso, Francesco Rossi, and Annalisa Capuano. Pharmacovigilance Study on the Reporting Frequency of Atrial Fibrillation with Immune Checkpoint Inhibitors: Insights from FDA Adverse Event Reporting System. SAGE Publishing.

MLA (9th ed.) Citation

Balzano, Nunzia, et al. Pharmacovigilance Study on the Reporting Frequency of Atrial Fibrillation with Immune Checkpoint Inhibitors: Insights from FDA Adverse Event Reporting System. SAGE Publishing.